Eljaszewicz Andrzej, Sienkiewicz Dorota, Grubczak Kamil, Okurowska-Zawada Bożena, Paszko-Patej Grażyna, Miklasz Paula, Singh Paulina, Radzikowska Urszula, Kulak Wojciech, Moniuszko Marcin
Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, 15-269 Bialystok, Poland.
Department of Pediatric Rehabilitation and Center of Early Support for Handicapped Children "Give a Chance", Medical University of Bialystok, 15-274 Bialystok, Poland.
Stem Cells Int. 2016;2016:2650849. doi: 10.1155/2016/2650849. Epub 2015 Dec 6.
Muscular dystrophies (MD) are heterogeneous group of diseases characterized by progressive muscle dysfunction. There is a large body of evidence indicating that angiogenesis is impaired in muscles of MD patients. Therefore, induction of dystrophic muscle revascularization should become a novel approach aimed at diminishing the extent of myocyte damage. Recently, we and others demonstrated that administration of granulocyte colony-stimulating factor (G-CSF) resulted in clinical improvement of patients with neuromuscular disorders. To date, however, the exact mechanisms underlying these beneficial effects of G-CSF have not been fully understood. Here we used flow cytometry to quantitate numbers of CD34+ cells, endothelial progenitor cells, and different monocyte subsets in peripheral blood of pediatric MD patients treated with repetitive courses of G-CSF administration. We showed that repetitive cycles of G-CSF administration induced efficient mobilization of above-mentioned cells including cells with proangiogenic potential. These findings contribute to better understanding the beneficial clinical effects of G-CSF in pediatric MD patients.
肌营养不良症(MD)是一组异质性疾病,其特征为进行性肌肉功能障碍。有大量证据表明,MD患者的肌肉中血管生成受损。因此,诱导营养不良性肌肉血管再生应成为一种旨在减少肌细胞损伤程度的新方法。最近,我们和其他人证明,给予粒细胞集落刺激因子(G-CSF)可使神经肌肉疾病患者的临床症状得到改善。然而,迄今为止,G-CSF这些有益作用的确切机制尚未完全明确。在此,我们使用流式细胞术对接受重复疗程G-CSF治疗的小儿MD患者外周血中CD34+细胞、内皮祖细胞和不同单核细胞亚群的数量进行定量。我们发现,重复给予G-CSF可有效动员上述细胞,包括具有促血管生成潜能的细胞。这些发现有助于更好地理解G-CSF对小儿MD患者的有益临床作用。